In the news

COVID-19 vaccines for children: Timing, side effects, and more


Dr. Lisa Doggett, Senior Medical Director, HGS AxisPoint Health, was featured in U.S. News & World Report as an immunization expert on COVID-19 vaccines for children

Lisa Doggett
U.S. News & World Report logo

Article originally published on U.S. News & World Report
Written by Dr. Lisa Doggett

Citing data curated by the New York Times, Dr. Lisa Doggett, senior medical director for HGS AxisPoint Health, a care management services company based in Westminster, Colorado, and a newly appointed fellow with American Academy of Family Physicians’ Vaccine Science Fellowship, says that more than “4.5 million people in the U.S between the ages of 12 and 18 years have received at least one dose of the vaccine.”

When kids younger than 12 will be eligible to receive the vaccine is still an open question, she adds. “Clinical trials are underway to assess vaccine effectiveness and safety in kids from age 6 months to 11 years old right now, and results are expected sometime later this year. I’m optimistic that kids in the 5- to 11-year-old age range will gain access to the vaccine this fall, but probably not in time for everyone to be fully vaccinated by the time schools reopen.”

If your child is younger than 12 and not currently eligible to receive a COVID-19 vaccine, it’s important to keep taking precautions to prevent infection. “We know that fortunately kids, especially younger kids, are at much lower risk of getting sick with COVID-19 than adults. That said, the risk is not zero,” Doggett says.

RECENT NEWS

data-analytics-customer-experience

How do I leverage data for better customer experience?

Consumers are providing brands with more personal data than…
Image of Henry and Anita

Webinar | Aging in place: Integrating fall risk assessment to ward off frailty

Donna Martin SVP Healthcare Business Developme…
Improve Customer Experience Using Marketing Automation
medical billing and coding

5 Provider Coding Myths, Debunked

Over the past 18 months, healthcare providers have grappled with historic cost and care challenges. The COVID-19 pandemic has increasingly forced providers to assess new areas of transformation to unlock operational value and cost efficiencies.

RECENT CASE STUDIES

Connect with our experts

X